See more : Lucas Bols N.V. (BOLS.AS) Income Statement Analysis – Financial Results
Complete financial analysis of Zepp Health Corporation (ZEPP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zepp Health Corporation, a leading company in the Consumer Electronics industry within the Technology sector.
You may be interested
- TECO 2030 ASA (TECO.OL) Income Statement Analysis – Financial Results
- BTM, Inc. (5247.T) Income Statement Analysis – Financial Results
- CCK Consolidated Holdings Berhad (7035.KL) Income Statement Analysis – Financial Results
- Rungta Irrigation Limited (RUNGTAIR.BO) Income Statement Analysis – Financial Results
- IL&FS Transportation Networks Limited (IL&FSTRANS.NS) Income Statement Analysis – Financial Results
Zepp Health Corporation (ZEPP)
About Zepp Health Corporation
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.50B | 4.14B | 6.25B | 6.43B | 5.81B | 3.65B | 2.05B | 1.56B | 896.46M |
| Cost of Revenue | 1.84B | 3.34B | 4.94B | 5.10B | 4.34B | 2.71B | 1.55B | 1.28B | 785.87M |
| Gross Profit | 657.78M | 803.12M | 1.31B | 1.33B | 1.47B | 939.45M | 494.70M | 276.15M | 110.59M |
| Gross Profit Ratio | 26.36% | 19.39% | 20.89% | 20.71% | 25.25% | 25.77% | 24.14% | 17.74% | 12.34% |
| Research & Development | 361.81M | 517.12M | 515.08M | 538.01M | 430.82M | 263.22M | 153.83M | 132.30M | 61.55M |
| General & Administrative | 188.51M | 235.93M | 258.35M | 261.81M | 248.46M | 213.97M | 114.88M | 102.64M | 69.98M |
| Selling & Marketing | 314.56M | 460.30M | 438.27M | 358.66M | 181.98M | 96.54M | 44.03M | 27.82M | 19.17M |
| SG&A | 503.07M | 696.24M | 696.62M | 620.46M | 430.44M | 310.51M | 158.91M | 130.47M | 89.15M |
| Other Expenses | 0.00 | 43.82M | 40.93M | -23.55M | 10.59M | 1.18M | 4.56M | 14.73M | 1.11M |
| Operating Expenses | 864.88M | 1.21B | 1.21B | 1.16B | 861.26M | 573.73M | 312.73M | 262.77M | 150.71M |
| Cost & Expenses | 2.70B | 4.55B | 6.16B | 6.26B | 5.21B | 3.28B | 1.87B | 1.54B | 936.57M |
| Interest Income | 3.09M | 12.33M | 16.69M | 46.12M | 33.48M | 11.60M | 3.00M | 754.00K | 255.00K |
| Interest Expense | 6.73M | 57.00M | 44.88M | 22.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 7.68M | 58.62M | 51.88M | 27.13M | 17.22M | 6.22M | 3.72M | 2.40M | 285.00K |
| EBITDA | -134.39M | -354.09M | 93.94M | 105.35M | 623.70M | 357.60M | 185.69M | 15.78M | -39.83M |
| EBITDA Ratio | -5.39% | -8.55% | 2.42% | 1.64% | 10.40% | 9.81% | 8.77% | 1.01% | -4.44% |
| Operating Income | -207.10M | -410.24M | 93.94M | 78.22M | 606.48M | 365.72M | 181.97M | 13.38M | -40.11M |
| Operating Income Ratio | -8.30% | -9.90% | 1.50% | 1.22% | 10.43% | 10.03% | 8.88% | 0.86% | -4.47% |
| Total Other Income/Expenses | 173.70M | 356.25M | -77.21M | -37.57M | -513.25M | -309.52M | -152.58M | 15.48M | 1.36M |
| Income Before Tax | -33.40M | -372.53M | 106.67M | 265.61M | 652.37M | 386.61M | 191.90M | 28.86M | -38.75M |
| Income Before Tax Ratio | -1.34% | -8.99% | 1.71% | 4.13% | 11.22% | 10.61% | 9.37% | 1.85% | -4.32% |
| Income Tax Expense | -2.23M | -65.88M | 10.75M | 31.15M | 77.89M | 52.04M | 27.61M | 3.09M | -897.00K |
| Net Income | -212.12M | -306.66M | 95.92M | 228.75M | 575.20M | 340.05M | 167.68M | 23.95M | -37.85M |
| Net Income Ratio | -8.50% | -7.40% | 1.53% | 3.56% | 9.90% | 9.33% | 8.18% | 1.54% | -4.22% |
| EPS | -13.96 | -4.98 | 1.52 | 3.68 | 9.44 | 6.08 | 0.78 | -0.20 | -0.64 |
| EPS Diluted | -13.96 | -4.98 | 1.45 | 3.51 | 8.99 | 6.04 | 0.78 | -0.20 | -0.64 |
| Weighted Avg Shares Out | 15.20M | 61.57M | 63.04M | 62.12M | 60.91M | 55.94M | 59.43M | 59.43M | 59.43M |
| Weighted Avg Shares Out (Dil) | 15.20M | 61.57M | 66.09M | 65.09M | 63.99M | 56.26M | 59.43M | 59.43M | 59.43M |
Zepp Health Corporation (ZEPP) CEO Wang Huang on Q1 2022 Results - Earnings Call Transcript
Zepp Health Corporation (NYSE:ZEPP ) Q1 2022 Earnings Conference Call May 24, 2022 8:00 AM ET Company Participants Grace Zhang - Director, IR Wang Huang - Chairman of Board of Directors & CEO Leon Deng - CFO Conference Call Participants...
Why Zepp Health Shares Are Trading Lower Today
Zepp Health Corp (NYSE: ZEPP) reported a first-quarter FY22 revenue decline of 34% year-on-year to $119.4 million, missing the consensus of $142.4 million. Drivers: Total units shipped decreased by 41.3% Y/Y to 3.7 million due to a 45.5% decrease in units of products built...
Zepp Health Corporation (ZEPP) CEO Wang Huang on Q4 2021 Results - Earnings Call Transcript
Zepp Health Corporation (ZEPP) CEO Wang Huang on Q4 2021 Results - Earnings Call Transcript
Zepp Health Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 17, 2022
BEIJING, March 1, 2022 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2021 unaudited financial...
Zepp Health Corporation (ZEPP) CEO Wang Huang on Q3 2021 Results - Earnings Call Transcript
Zepp Health Corporation (ZEPP) CEO Wang Huang on Q3 2021 Results - Earnings Call Transcript
Zepp Health Corp. to Report Third Quarter 2021 Financial Results on November 16, 2021
BEIJING, Nov. 1, 2021 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its third quarter of 2021 unaudited financial results before the market...
Fashion Designer Christian Cowan is Smart Wearable Brand Amazfit's New GTR 3 and GTS 3 Series Experience Consultant
NEW YORK, Oct. 12, 2021 /PRNewswire/ -- Leading global smart wearable brand, Amazfit , announced today an exciting new partnership with fashion trailblazer Christian Cowan who becomes the brand's official GTR 3 and GTS 3 Series Experience Consultant. The partnership...
Amazfit Unveils Bold New Brand Identity as Global Smartwatch Launch Inspires Everyone to UP YOUR GAME
NEW YORK, Oct. 11, 2021 /PRNewswire/ -- Amazfit , a global leader of wearable and smart technology, has unveiled a fresh brand identity that celebrates self-expression and more boldly reflects its customers' values and lifestyles. Amazfit is a brand owned...
Zepp: A Solid International Diversification Play
Shares of Zepp are down nearly 40% third year, worse than most other Chinese stocks (the Hang Seng is down only 11%). Zepp is experiencing rapid revenue growth, thanks to continued success of its branded products and diversification of its...
3 Stocks That Appear to Be Undervalued by the Market
When screening the market for value opportunities, investors could be interested in the following stocks since their prices are trading at a discount to the intrinsic value calculated by GuruFocus' earnings-based discounted cash flow calculator.
Source: https://incomestatements.info
Category: Stock Reports
What are the key factors affecting Zepp Health’s financial performance?
A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the cooperation with Xiaomi, the recognition of the Company’s self-branded products; the Company’s growth strategies; trends and competition in global …